- Home
- XXII vs CELZ Comparison
XXII vs CELZ Comparison
Compare XXII & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- CELZ
- Stock Information
- Founded
- XXII 1998
- CELZ 1998
- Country
- XXII United States
- CELZ United States
- Employees
- XXII N/A
- CELZ N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- XXII Health Care
- CELZ Health Care
- Exchange
- XXII Nasdaq
- CELZ Nasdaq
- Market Cap
- XXII 3.9M
- CELZ 4.7M
- IPO Year
- XXII N/A
- CELZ N/A
- Fundamental
- Price
- XXII $5.50
- CELZ $2.26
- Analyst Decision
- XXII
- CELZ
- Analyst Count
- XXII 0
- CELZ 0
- Target Price
- XXII N/A
- CELZ N/A
- AVG Volume (30 Days)
- XXII 9.7M
- CELZ 23.0K
- Earning Date
- XXII 11-12-2024
- CELZ 11-08-2024
- Dividend Yield
- XXII N/A
- CELZ N/A
- EPS Growth
- XXII N/A
- CELZ N/A
- EPS
- XXII N/A
- CELZ N/A
- Revenue
- XXII $17,304,000.00
- CELZ $11,000.00
- Revenue This Year
- XXII $56.94
- CELZ N/A
- Revenue Next Year
- XXII $2.98
- CELZ N/A
- P/E Ratio
- XXII N/A
- CELZ N/A
- Revenue Growth
- XXII N/A
- CELZ N/A
- 52 Week Low
- XXII $3.90
- CELZ $2.12
- 52 Week High
- XXII $581.85
- CELZ $10.28
- Technical
- Relative Strength Index (RSI)
- XXII 18.51
- CELZ 35.64
- Support Level
- XXII $3.90
- CELZ $2.12
- Resistance Level
- XXII $12.29
- CELZ $2.50
- Average True Range (ATR)
- XXII 1.06
- CELZ 0.19
- MACD
- XXII -0.59
- CELZ 0.02
- Stochastic Oscillator
- XXII 4.36
- CELZ 26.55
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.